As the global economy mends, the 2021 growth of Imipenem API will have significant change from previous year. According to our (LP Information) latest study, the global Imipenem API market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Imipenem API market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.
The United States Imipenem API market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Imipenem API market, reaching US$ million by the year 2028. As for the Europe Imipenem API landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Imipenem API players cover Hospira, ACS DOBFAR SPA, High Science, and Jeil Pharmaceutica, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Imipenem API market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
- Aseptic API
- Non-sterile API
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
- Intramuscular Injection
- Static Drops
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
- Americas
- - United States
- - Canada
- - Mexico
- - Brazil
- APAC
- - China
- - Japan
- - Korea
- - Southeast Asia
- - India
- - Australia
- Europe
- - Germany
- - France
- - UK
- - Italy
- - Russia
- Middle East & Africa
- - Egypt
- - South Africa
- - Israel
- - Turkey
- - GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
- Hospira
- ACS DOBFAR SPA
- High Science
- Jeil Pharmaceutica
- Choongwae Pharma Corporation
- Sun Pharmaceutical
- Sandoz
- Kaliberr
- Auronext Pharma
- Nectar Lifesciences
- Savior Lifetec Corporation
- Zhuhai United Laboratorie
- SUZHOU HOMESUN PHARMACEUTICAL
- Unimark Remedies
- Zhejiang Haixiang Pharmaceutical
Global Imipenem API Market Growth 2022-2028
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Imipenem API Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Imipenem API by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Imipenem API by Country/Region, 2017, 2022 & 2028
2.2 Imipenem API Segment by Type
2.2.1 Aseptic API
2.2.2 Non-sterile API
2.3 Imipenem API Sales by Type
2.3.1 Global Imipenem API Sales Market Share by Type (2017-2022)
2.3.2 Global Imipenem API Revenue and Market Share by Type (2017-2022)
2.3.3 Global Imipenem API Sale Price by Type (2017-2022)
2.4 Imipenem API Segment by Application
2.4.1 Intramuscular Injection
2.4.2 Static Drops
2.5 Imipenem API Sales by Application
2.5.1 Global Imipenem API Sale Market Share by Application (2017-2022)
2.5.2 Global Imipenem API Revenue and Market Share by Application (2017-2022)
2.5.3 Global Imipenem API Sale Price by Application (2017-2022)
3 Global Imipenem API by Company
3.1 Global Imipenem API Breakdown Data by Company
3.1.1 Global Imipenem API Annual Sales by Company (2020-2022)
3.1.2 Global Imipenem API Sales Market Share by Company (2020-2022)
3.2 Global Imipenem API Annual Revenue by Company (2020-2022)
3.2.1 Global Imipenem API Revenue by Company (2020-2022)
3.2.2 Global Imipenem API Revenue Market Share by Company (2020-2022)
3.3 Global Imipenem API Sale Price by Company
3.4 Key Manufacturers Imipenem API Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Imipenem API Product Location Distribution
3.4.2 Players Imipenem API Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Imipenem API by Geographic Region
4.1 World Historic Imipenem API Market Size by Geographic Region (2017-2022)
4.1.1 Global Imipenem API Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Imipenem API Annual Revenue by Geographic Region
4.2 World Historic Imipenem API Market Size by Country/Region (2017-2022)
4.2.1 Global Imipenem API Annual Sales by Country/Region (2017-2022)
4.2.2 Global Imipenem API Annual Revenue by Country/Region
4.3 Americas Imipenem API Sales Growth
4.4 APAC Imipenem API Sales Growth
4.5 Europe Imipenem API Sales Growth
4.6 Middle East & Africa Imipenem API Sales Growth
5 Americas
5.1 Americas Imipenem API Sales by Country
5.1.1 Americas Imipenem API Sales by Country (2017-2022)
5.1.2 Americas Imipenem API Revenue by Country (2017-2022)
5.2 Americas Imipenem API Sales by Type
5.3 Americas Imipenem API Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Imipenem API Sales by Region
6.1.1 APAC Imipenem API Sales by Region (2017-2022)
6.1.2 APAC Imipenem API Revenue by Region (2017-2022)
6.2 APAC Imipenem API Sales by Type
6.3 APAC Imipenem API Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Imipenem API by Country
7.1.1 Europe Imipenem API Sales by Country (2017-2022)
7.1.2 Europe Imipenem API Revenue by Country (2017-2022)
7.2 Europe Imipenem API Sales by Type
7.3 Europe Imipenem API Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Imipenem API by Country
8.1.1 Middle East & Africa Imipenem API Sales by Country (2017-2022)
8.1.2 Middle East & Africa Imipenem API Revenue by Country (2017-2022)
8.2 Middle East & Africa Imipenem API Sales by Type
8.3 Middle East & Africa Imipenem API Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Imipenem API
10.3 Manufacturing Process Analysis of Imipenem API
10.4 Industry Chain Structure of Imipenem API
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Imipenem API Distributors
11.3 Imipenem API Customer
12 World Forecast Review for Imipenem API by Geographic Region
12.1 Global Imipenem API Market Size Forecast by Region
12.1.1 Global Imipenem API Forecast by Region (2023-2028)
12.1.2 Global Imipenem API Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Imipenem API Forecast by Type
12.7 Global Imipenem API Forecast by Application
13 Key Players Analysis
13.1 Hospira
13.1.1 Hospira Company Information
13.1.2 Hospira Imipenem API Product Offered
13.1.3 Hospira Imipenem API Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Hospira Main Business Overview
13.1.5 Hospira Latest Developments
13.2 ACS DOBFAR SPA
13.2.1 ACS DOBFAR SPA Company Information
13.2.2 ACS DOBFAR SPA Imipenem API Product Offered
13.2.3 ACS DOBFAR SPA Imipenem API Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 ACS DOBFAR SPA Main Business Overview
13.2.5 ACS DOBFAR SPA Latest Developments
13.3 High Science
13.3.1 High Science Company Information
13.3.2 High Science Imipenem API Product Offered
13.3.3 High Science Imipenem API Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 High Science Main Business Overview
13.3.5 High Science Latest Developments
13.4 Jeil Pharmaceutica
13.4.1 Jeil Pharmaceutica Company Information
13.4.2 Jeil Pharmaceutica Imipenem API Product Offered
13.4.3 Jeil Pharmaceutica Imipenem API Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Jeil Pharmaceutica Main Business Overview
13.4.5 Jeil Pharmaceutica Latest Developments
13.5 Choongwae Pharma Corporation
13.5.1 Choongwae Pharma Corporation Company Information
13.5.2 Choongwae Pharma Corporation Imipenem API Product Offered
13.5.3 Choongwae Pharma Corporation Imipenem API Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Choongwae Pharma Corporation Main Business Overview
13.5.5 Choongwae Pharma Corporation Latest Developments
13.6 Sun Pharmaceutical
13.6.1 Sun Pharmaceutical Company Information
13.6.2 Sun Pharmaceutical Imipenem API Product Offered
13.6.3 Sun Pharmaceutical Imipenem API Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Sun Pharmaceutical Main Business Overview
13.6.5 Sun Pharmaceutical Latest Developments
13.7 Sandoz
13.7.1 Sandoz Company Information
13.7.2 Sandoz Imipenem API Product Offered
13.7.3 Sandoz Imipenem API Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Sandoz Main Business Overview
13.7.5 Sandoz Latest Developments
13.8 Kaliberr
13.8.1 Kaliberr Company Information
13.8.2 Kaliberr Imipenem API Product Offered
13.8.3 Kaliberr Imipenem API Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Kaliberr Main Business Overview
13.8.5 Kaliberr Latest Developments
13.9 Auronext Pharma
13.9.1 Auronext Pharma Company Information
13.9.2 Auronext Pharma Imipenem API Product Offered
13.9.3 Auronext Pharma Imipenem API Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Auronext Pharma Main Business Overview
13.9.5 Auronext Pharma Latest Developments
13.10 Nectar Lifesciences
13.10.1 Nectar Lifesciences Company Information
13.10.2 Nectar Lifesciences Imipenem API Product Offered
13.10.3 Nectar Lifesciences Imipenem API Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Nectar Lifesciences Main Business Overview
13.10.5 Nectar Lifesciences Latest Developments
13.11 Savior Lifetec Corporation
13.11.1 Savior Lifetec Corporation Company Information
13.11.2 Savior Lifetec Corporation Imipenem API Product Offered
13.11.3 Savior Lifetec Corporation Imipenem API Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Savior Lifetec Corporation Main Business Overview
13.11.5 Savior Lifetec Corporation Latest Developments
13.12 Zhuhai United Laboratorie
13.12.1 Zhuhai United Laboratorie Company Information
13.12.2 Zhuhai United Laboratorie Imipenem API Product Offered
13.12.3 Zhuhai United Laboratorie Imipenem API Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Zhuhai United Laboratorie Main Business Overview
13.12.5 Zhuhai United Laboratorie Latest Developments
13.13 SUZHOU HOMESUN PHARMACEUTICAL
13.13.1 SUZHOU HOMESUN PHARMACEUTICAL Company Information
13.13.2 SUZHOU HOMESUN PHARMACEUTICAL Imipenem API Product Offered
13.13.3 SUZHOU HOMESUN PHARMACEUTICAL Imipenem API Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 SUZHOU HOMESUN PHARMACEUTICAL Main Business Overview
13.13.5 SUZHOU HOMESUN PHARMACEUTICAL Latest Developments
13.14 Unimark Remedies
13.14.1 Unimark Remedies Company Information
13.14.2 Unimark Remedies Imipenem API Product Offered
13.14.3 Unimark Remedies Imipenem API Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 Unimark Remedies Main Business Overview
13.14.5 Unimark Remedies Latest Developments
13.15 Zhejiang Haixiang Pharmaceutical
13.15.1 Zhejiang Haixiang Pharmaceutical Company Information
13.15.2 Zhejiang Haixiang Pharmaceutical Imipenem API Product Offered
13.15.3 Zhejiang Haixiang Pharmaceutical Imipenem API Sales, Revenue, Price and Gross Margin (2020-2022)
13.15.4 Zhejiang Haixiang Pharmaceutical Main Business Overview
13.15.5 Zhejiang Haixiang Pharmaceutical Latest Developments
14 Research Findings and Conclusion
List of Tables
Table 1. Imipenem API Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Imipenem API Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Aseptic API
Table 4. Major Players of Non-sterile API
Table 5. Global Imipenem API Sales by Type (2017-2022) & (KG)
Table 6. Global Imipenem API Sales Market Share by Type (2017-2022)
Table 7. Global Imipenem API Revenue by Type (2017-2022) & ($ million)
Table 8. Global Imipenem API Revenue Market Share by Type (2017-2022)
Table 9. Global Imipenem API Sale Price by Type (2017-2022) & (US$/G)
Table 10. Global Imipenem API Sales by Application (2017-2022) & (KG)
Table 11. Global Imipenem API Sales Market Share by Application (2017-2022)
Table 12. Global Imipenem API Revenue by Application (2017-2022)
Table 13. Global Imipenem API Revenue Market Share by Application (2017-2022)
Table 14. Global Imipenem API Sale Price by Application (2017-2022) & (US$/G)
Table 15. Global Imipenem API Sales by Company (2020-2022) & (KG)
Table 16. Global Imipenem API Sales Market Share by Company (2020-2022)
Table 17. Global Imipenem API Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Imipenem API Revenue Market Share by Company (2020-2022)
Table 19. Global Imipenem API Sale Price by Company (2020-2022) & (US$/G)
Table 20. Key Manufacturers Imipenem API Producing Area Distribution and Sales Area
Table 21. Players Imipenem API Products Offered
Table 22. Imipenem API Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Imipenem API Sales by Geographic Region (2017-2022) & (KG)
Table 26. Global Imipenem API Sales Market Share Geographic Region (2017-2022)
Table 27. Global Imipenem API Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Imipenem API Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Imipenem API Sales by Country/Region (2017-2022) & (KG)
Table 30. Global Imipenem API Sales Market Share by Country/Region (2017-2022)
Table 31. Global Imipenem API Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Imipenem API Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Imipenem API Sales by Country (2017-2022) & (KG)
Table 34. Americas Imipenem API Sales Market Share by Country (2017-2022)
Table 35. Americas Imipenem API Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Imipenem API Revenue Market Share by Country (2017-2022)
Table 37. Americas Imipenem API Sales by Type (2017-2022) & (KG)
Table 38. Americas Imipenem API Sales Market Share by Type (2017-2022)
Table 39. Americas Imipenem API Sales by Application (2017-2022) & (KG)
Table 40. Americas Imipenem API Sales Market Share by Application (2017-2022)
Table 41. APAC Imipenem API Sales by Region (2017-2022) & (KG)
Table 42. APAC Imipenem API Sales Market Share by Region (2017-2022)
Table 43. APAC Imipenem API Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Imipenem API Revenue Market Share by Region (2017-2022)
Table 45. APAC Imipenem API Sales by Type (2017-2022) & (KG)
Table 46. APAC Imipenem API Sales Market Share by Type (2017-2022)
Table 47. APAC Imipenem API Sales by Application (2017-2022) & (KG)
Table 48. APAC Imipenem API Sales Market Share by Application (2017-2022)
Table 49. Europe Imipenem API Sales by Country (2017-2022) & (KG)
Table 50. Europe Imipenem API Sales Market Share by Country (2017-2022)
Table 51. Europe Imipenem API Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Imipenem API Revenue Market Share by Country (2017-2022)
Table 53. Europe Imipenem API Sales by Type (2017-2022) & (KG)
Table 54. Europe Imipenem API Sales Market Share by Type (2017-2022)
Table 55. Europe Imipenem API Sales by Application (2017-2022) & (KG)
Table 56. Europe Imipenem API Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Imipenem API Sales by Country (2017-2022) & (KG)
Table 58. Middle East & Africa Imipenem API Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Imipenem API Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Imipenem API Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Imipenem API Sales by Type (2017-2022) & (KG)
Table 62. Middle East & Africa Imipenem API Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Imipenem API Sales by Application (2017-2022) & (KG)
Table 64. Middle East & Africa Imipenem API Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Imipenem API
Table 66. Key Market Challenges & Risks of Imipenem API
Table 67. Key Industry Trends of Imipenem API
Table 68. Imipenem API Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Imipenem API Distributors List
Table 71. Imipenem API Customer List
Table 72. Global Imipenem API Sales Forecast by Region (2023-2028) & (KG)
Table 73. Global Imipenem API Sales Market Forecast by Region
Table 74. Global Imipenem API Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Imipenem API Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Imipenem API Sales Forecast by Country (2023-2028) & (KG)
Table 77. Americas Imipenem API Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Imipenem API Sales Forecast by Region (2023-2028) & (KG)
Table 79. APAC Imipenem API Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Imipenem API Sales Forecast by Country (2023-2028) & (KG)
Table 81. Europe Imipenem API Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Imipenem API Sales Forecast by Country (2023-2028) & (KG)
Table 83. Middle East & Africa Imipenem API Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Imipenem API Sales Forecast by Type (2023-2028) & (KG)
Table 85. Global Imipenem API Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Imipenem API Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Imipenem API Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Imipenem API Sales Forecast by Application (2023-2028) & (KG)
Table 89. Global Imipenem API Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Imipenem API Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Imipenem API Revenue Market Share Forecast by Application (2023-2028)
Table 92. Hospira Basic Information, Imipenem API Manufacturing Base, Sales Area and Its Competitors
Table 93. Hospira Imipenem API Product Offered
Table 94. Hospira Imipenem API Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)
Table 95. Hospira Main Business
Table 96. Hospira Latest Developments
Table 97. ACS DOBFAR SPA Basic Information, Imipenem API Manufacturing Base, Sales Area and Its Competitors
Table 98. ACS DOBFAR SPA Imipenem API Product Offered
Table 99. ACS DOBFAR SPA Imipenem API Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)
Table 100. ACS DOBFAR SPA Main Business
Table 101. ACS DOBFAR SPA Latest Developments
Table 102. High Science Basic Information, Imipenem API Manufacturing Base, Sales Area and Its Competitors
Table 103. High Science Imipenem API Product Offered
Table 104. High Science Imipenem API Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)
Table 105. High Science Main Business
Table 106. High Science Latest Developments
Table 107. Jeil Pharmaceutica Basic Information, Imipenem API Manufacturing Base, Sales Area and Its Competitors
Table 108. Jeil Pharmaceutica Imipenem API Product Offered
Table 109. Jeil Pharmaceutica Imipenem API Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)
Table 110. Jeil Pharmaceutica Main Business
Table 111. Jeil Pharmaceutica Latest Developments
Table 112. Choongwae Pharma Corporation Basic Information, Imipenem API Manufacturing Base, Sales Area and Its Competitors
Table 113. Choongwae Pharma Corporation Imipenem API Product Offered
Table 114. Choongwae Pharma Corporation Imipenem API Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)
Table 115. Choongwae Pharma Corporation Main Business
Table 116. Choongwae Pharma Corporation Latest Developments
Table 117. Sun Pharmaceutical Basic Information, Imipenem API Manufacturing Base, Sales Area and Its Competitors
Table 118. Sun Pharmaceutical Imipenem API Product Offered
Table 119. Sun Pharmaceutical Imipenem API Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)
Table 120. Sun Pharmaceutical Main Business
Table 121. Sun Pharmaceutical Latest Developments
Table 122. Sandoz Basic Information, Imipenem API Manufacturing Base, Sales Area and Its Competitors
Table 123. Sandoz Imipenem API Product Offered
Table 124. Sandoz Imipenem API Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)
Table 125. Sandoz Main Business
Table 126. Sandoz Latest Developments
Table 127. Kaliberr Basic Information, Imipenem API Manufacturing Base, Sales Area and Its Competitors
Table 128. Kaliberr Imipenem API Product Offered
Table 129. Kaliberr Imipenem API Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)
Table 130. Kaliberr Main Business
Table 131. Kaliberr Latest Developments
Table 132. Auronext Pharma Basic Information, Imipenem API Manufacturing Base, Sales Area and Its Competitors
Table 133. Auronext Pharma Imipenem API Product Offered
Table 134. Auronext Pharma Imipenem API Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)
Table 135. Auronext Pharma Main Business
Table 136. Auronext Pharma Latest Developments
Table 137. Nectar Lifesciences Basic Information, Imipenem API Manufacturing Base, Sales Area and Its Competitors
Table 138. Nectar Lifesciences Imipenem API Product Offered
Table 139. Nectar Lifesciences Imipenem API Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)
Table 140. Nectar Lifesciences Main Business
Table 141. Nectar Lifesciences Latest Developments
Table 142. Savior Lifetec Corporation Basic Information, Imipenem API Manufacturing Base, Sales Area and Its Competitors
Table 143. Savior Lifetec Corporation Imipenem API Product Offered
Table 144. Savior Lifetec Corporation Imipenem API Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)
Table 145. Savior Lifetec Corporation Main Business
Table 146. Savior Lifetec Corporation Latest Developments
Table 147. Zhuhai United Laboratorie Basic Information, Imipenem API Manufacturing Base, Sales Area and Its Competitors
Table 148. Zhuhai United Laboratorie Imipenem API Product Offered
Table 149. Zhuhai United Laboratorie Imipenem API Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)
Table 150. Zhuhai United Laboratorie Main Business
Table 151. Zhuhai United Laboratorie Latest Developments
Table 152. SUZHOU HOMESUN PHARMACEUTICAL Basic Information, Imipenem API Manufacturing Base, Sales Area and Its Competitors
Table 153. SUZHOU HOMESUN PHARMACEUTICAL Imipenem API Product Offered
Table 154. SUZHOU HOMESUN PHARMACEUTICAL Imipenem API Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)
Table 155. SUZHOU HOMESUN PHARMACEUTICAL Main Business
Table 156. SUZHOU HOMESUN PHARMACEUTICAL Latest Developments
Table 157. Unimark Remedies Basic Information, Imipenem API Manufacturing Base, Sales Area and Its Competitors
Table 158. Unimark Remedies Imipenem API Product Offered
Table 159. Unimark Remedies Imipenem API Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)
Table 160. Unimark Remedies Main Business
Table 161. Unimark Remedies Latest Developments
Table 162. Zhejiang Haixiang Pharmaceutical Basic Information, Imipenem API Manufacturing Base, Sales Area and Its Competitors
Table 163. Zhejiang Haixiang Pharmaceutical Imipenem API Product Offered
Table 164. Zhejiang Haixiang Pharmaceutical Imipenem API Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)
Table 165. Zhejiang Haixiang Pharmaceutical Main Business
Table 166. Zhejiang Haixiang Pharmaceutical Latest Developments
List of Figures
Figure 1. Picture of Imipenem API
Figure 2. Imipenem API Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Imipenem API Sales Growth Rate 2017-2028 (KG)
Figure 7. Global Imipenem API Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Imipenem API Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Aseptic API
Figure 10. Product Picture of Non-sterile API
Figure 11. Global Imipenem API Sales Market Share by Type in 2021
Figure 12. Global Imipenem API Revenue Market Share by Type (2017-2022)
Figure 13. Imipenem API Consumed in Intramuscular Injection
Figure 14. Global Imipenem API Market: Intramuscular Injection (2017-2022) & (KG)
Figure 15. Imipenem API Consumed in Static Drops
Figure 16. Global Imipenem API Market: Static Drops (2017-2022) & (KG)
Figure 17. Global Imipenem API Sales Market Share by Application (2017-2022)
Figure 18. Global Imipenem API Revenue Market Share by Application in 2021
Figure 19. Imipenem API Revenue Market by Company in 2021 ($ Million)
Figure 20. Global Imipenem API Revenue Market Share by Company in 2021
Figure 21. Global Imipenem API Sales Market Share by Geographic Region (2017-2022)
Figure 22. Global Imipenem API Revenue Market Share by Geographic Region in 2021
Figure 23. Global Imipenem API Sales Market Share by Region (2017-2022)
Figure 24. Global Imipenem API Revenue Market Share by Country/Region in 2021
Figure 25. Americas Imipenem API Sales 2017-2022 (KG)
Figure 26. Americas Imipenem API Revenue 2017-2022 ($ Millions)
Figure 27. APAC Imipenem API Sales 2017-2022 (KG)
Figure 28. APAC Imipenem API Revenue 2017-2022 ($ Millions)
Figure 29. Europe Imipenem API Sales 2017-2022 (KG)
Figure 30. Europe Imipenem API Revenue 2017-2022 ($ Millions)
Figure 31. Middle East & Africa Imipenem API Sales 2017-2022 (KG)
Figure 32. Middle East & Africa Imipenem API Revenue 2017-2022 ($ Millions)
Figure 33. Americas Imipenem API Sales Market Share by Country in 2021
Figure 34. Americas Imipenem API Revenue Market Share by Country in 2021
Figure 35. United States Imipenem API Revenue Growth 2017-2022 ($ Millions)
Figure 36. Canada Imipenem API Revenue Growth 2017-2022 ($ Millions)
Figure 37. Mexico Imipenem API Revenue Growth 2017-2022 ($ Millions)
Figure 38. Brazil Imipenem API Revenue Growth 2017-2022 ($ Millions)
Figure 39. APAC Imipenem API Sales Market Share by Region in 2021
Figure 40. APAC Imipenem API Revenue Market Share by Regions in 2021
Figure 41. China Imipenem API Revenue Growth 2017-2022 ($ Millions)
Figure 42. Japan Imipenem API Revenue Growth 2017-2022 ($ Millions)
Figure 43. South Korea Imipenem API Revenue Growth 2017-2022 ($ Millions)
Figure 44. Southeast Asia Imipenem API Revenue Growth 2017-2022 ($ Millions)
Figure 45. India Imipenem API Revenue Growth 2017-2022 ($ Millions)
Figure 46. Australia Imipenem API Revenue Growth 2017-2022 ($ Millions)
Figure 47. Europe Imipenem API Sales Market Share by Country in 2021
Figure 48. Europe Imipenem API Revenue Market Share by Country in 2021
Figure 49. Germany Imipenem API Revenue Growth 2017-2022 ($ Millions)
Figure 50. France Imipenem API Revenue Growth 2017-2022 ($ Millions)
Figure 51. UK Imipenem API Revenue Growth 2017-2022 ($ Millions)
Figure 52. Italy Imipenem API Revenue Growth 2017-2022 ($ Millions)
Figure 53. Russia Imipenem API Revenue Growth 2017-2022 ($ Millions)
Figure 54. Middle East & Africa Imipenem API Sales Market Share by Country in 2021
Figure 55. Middle East & Africa Imipenem API Revenue Market Share by Country in 2021
Figure 56. Egypt Imipenem API Revenue Growth 2017-2022 ($ Millions)
Figure 57. South Africa Imipenem API Revenue Growth 2017-2022 ($ Millions)
Figure 58. Israel Imipenem API Revenue Growth 2017-2022 ($ Millions)
Figure 59. Turkey Imipenem API Revenue Growth 2017-2022 ($ Millions)
Figure 60. GCC Country Imipenem API Revenue Growth 2017-2022 ($ Millions)
Figure 61. Manufacturing Cost Structure Analysis of Imipenem API in 2021
Figure 62. Manufacturing Process Analysis of Imipenem API
Figure 63. Industry Chain Structure of Imipenem API
Figure 64. Channels of Distribution
Figure 65. Distributors Profiles
Global Antioxidant Vitamins Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 100
The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
Global Clavulanate Potassium Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 86
The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030.
North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
Global Amoxicillin Sodium Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 84
The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030.
North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
Global Melatonin Supplements Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 106
The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 93
The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
Global Sleeping Pills Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 94
The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
Global Zinc Oral Drops Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 85
The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
Global Zinc Drops Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 85
The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
Global Anti-Infectives Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 78
The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
